The Source for High Quality Small Molecule Kinase Inhibitors

SYNkinase's mission is to provide life science researchers with access to the world's most up-to-date library of kinase inhibitors and other small molecule inhibitors of important therapeutic proteins for drug discovery. SYNkinase offers a library of potent, pure and research-relevant inhibitors directed against specific protein serine/threonine kinases (PS/TKs), protein tyrosine kinases (PTK & RTK) as well as lipid kinases. There are more than 150 kinase targeted drugs in clinical trials or development at present. Twenty-four small molecule inhibitors have been FDA-approved including mTOR, BRaf, MEK, EGFR, JAK, VEGFR and PI3K inhibitors. SYNkinase has many of these compounds available for sale as well as a large range of inhibitors described in the literature such as GPCR, TGF-β, MAP kinase, cell cycle and epigenetic inhibitors. As a primary source manufacturer, SYNkinase maintains a fastidious focus on quality, ensuring that they can consistently supply the same high quality material, as well as being first in the market with the most important and cutting-edge compounds.

SYNKinase Inhibitor Product Flyer	SYNKinase Libraries Product Flyer	General Catalog